APA (7th ed.) Citation

Coutinho, M. F., Santos, J. I., Mendonça, L. S., Matos, L., Prata, M. J., Jurado, A. S., . . . Alves, S. (2021). Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated siRNAs to the Brain as a Therapeutic Approach: The Sanfilippo Syndrome example.

Chicago Style (17th ed.) Citation

Coutinho, Maria Francisca, Juliana Inês Santos, Liliana Silva Mendonça, Liliana Matos, Maria João Prata, Amália Silva Jurado, Maria da Conceição Pedroso de Lima, and Sandra Alves. Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated SiRNAs to the Brain as a Therapeutic Approach: The Sanfilippo Syndrome Example. 2021.

MLA (8th ed.) Citation

Coutinho, Maria Francisca, et al. Lysosomal Storage Disease-Associated Neuropathy: Targeting Stable Nucleic Acid Lipid Particle (SNALP)-Formulated SiRNAs to the Brain as a Therapeutic Approach: The Sanfilippo Syndrome Example. 2021.